Mastery EAQ Ch. 10

A  Analgesics should be administered as needed to minimize adverse effects.

B  Pain relief is best obtained by administering analgesics around the clock.

C  Narcotic analgesics should not be used for more than 24 hours.

D  Patients should request analgesics when the pain level reaches a 3 on a scale of 1 to 10.

A  Altered consciousness, Excess urination, Change in sputum color

B  Slow pupil reaction, Excess urination, Change in sputum color

C  Excess urination, Hallucinations, Change in sputum color

D  Hallucinations, Slow pupil reaction, Altered consciousness

A  Placed on a hairy area

B  Placed on an area after cleaning it

C  Placed on the same place as the old patch

D  Placed on a new area, with the old patch still in place

A  Ask the patient to bear the pain until the next scheduled opioid dose.

B  Administer the scheduled opioid dose early.

C  Administer a short-acting opioid and follow the regular opioid schedule for the next dose.

D  Distract the patient for 2 hours by using alternative methods, such as music therapy.

A  “Increase the dose of morphine if there is no relief of pain.”
“Take acetaminophen with the morphine.”

B  “Drink at least 3 liters of fluid a day.”
“Take an over-the-counter stool softener daily.”

C  “Increase the dose of morphine if there is no relief of pain.”
“Rest before taking the medication.”

D  “Rest before taking the medication.”
“Take acetaminophen with the morphine.”

A  Assess arterial blood gases.

B  Prepare for intubation.

C  Call the respiratory team stat.

D  Administer naloxone.

A  Hyperactive bowel sounds

B  Diarrhea

C  Insomnia

D  Sedation

A  “Do not crush the medication.”
“Swallow the medication whole.”
“Do not dissolve the medication in water.”

B  “Do not dissolve the medication in water.”
“Take the medication frequently.”
“Increase the dose if you experience no pain relief.”

C  “Take the medication frequently.”
“Increase the dose if you experience no pain relief.”
“Do not crush the medication.”

D  “Take the medication frequently.”
“Swallow the medication whole.”
“Increase the dose if you experience no pain relief.”

A  Anorexia

B  Cancer

C  Asthma

D  Diarrhea

A  Assess blood gases.

B  Reassess the patient in an hour.

C  Administer a narcotic antagonist.

D  Assess the patient’s neurologic status.

A  Random blood glucose 140 mg/dL

B  Serum creatinine 0.8 mg/dL

C  Serum bilirubin 3.2 mg/dL

D  Hemoglobin 11.2 g/dL

A  Consult the primary health care provider and obtain another drug prescription.

B  Hold the drug, record the assessment, and reassess the patient in 1 hour.

C  Administer another 1 mg of morphine and reevaluate the pain scale in 15 minutes.

D  Administer 1 mg of morphine and notify the primary health care provider.

A  Acetylcysteine

B  Naloxone

C  Protamine sulfate

D  Methylprednisolone

A  Inform the primary health care provider.

B  Administer an opioid antagonist.

C  Withhold the scheduled opioid dose.

D  Administer the scheduled opioid dose.

A  “There’s no needle. It’s a thin plastic tube in the protective covering of your spinal cord.”

B  “Tell me more about your understanding of how epidural analgesia relieves your pain.”

C  “If you don’t turn, cough, and breathe deeply, you may get pneumonia or other complications.”

D  “I can understand your fears, but there is no risk of paralysis from epidural analgesia.”

A  Acetylcysteine

B  Nalbuphine

C  Naltrexone hydrochloride

D  Naloxone

A  Within 2 hours

B  In 4 hours

C  Within a half hour

D  In 8 hours

A  Respiratory rate 28 breaths/min

B  Heart rate 110 beats/min

C  Blood in urine

D  Pinpoint pupils

A  Assess the patients’ responsiveness.

B  Administer flumazenil.

C  Prepare intravenous naloxone.

D  Initiate resuscitative measures.

A  Respiratory rate

B  Circulation

C  Cough reflex

D  Chemoreceptor trigger zone

A  Respiratory rate 12 breaths/min

B  Vague feeling of anxiety

C  Heart rate 90 beats/min

D  No bowel movement in 72 hours

A  Administer an amphetamine.

B  Assess the patient for pain.

C  Administer naltrexone hydrochloride.

D  Assess the patient’s electrocardiogram (ECG).

A  Questions regarding past history of drug and alcohol use

B  Questions regarding the date of the last flu vaccine

C  Assessment of chronic diseases causing pain

D  Assessment of culture reports

A  Joint pain, Skin rashes, Blurred vision

B  Skin rashes, Blurred vision, Nausea

C  Nausea, Joint pain, Muscle stiffness

D  Skin rashes, Muscle stiffness, Blurred vision

A  “Store the patches in the bathroom medicine cabinet.”

B  “Dispose of patches by melting them with a flame.”

C  “Keep new and used patches away from children.”

D  “Apply heat over the patch to increase absorption.”

A  Binds and causes less pain response than an agonist

B  Binds in place of the agonist and causes no response

C  Binds instead of the agonist and causes analgesia

D  Binds and causes a response opposite to that of an agonist

A  107 mg

B  150 mg

C  100 mg

D  125 mg

A  Visceral pain

B  Deep pain

C  Somatic pain

D  Superficial pain

A  Dizziness

B  Constipation

C  Diarrhea

D  Miosis

A  “This medication helps open up your airways.”

B  “This medication will help you get rid of mucous.”

C  “This medication is used as a cough suppressant.”

D  “This medication will help your immune system.”

A  “Everything will be fine. You will be back to work in about 6 weeks.”

B  “Your pain is well controlled now. Why are you so worried?”

C  “The disability benefit of your insurance plan will help pay your bills.”

D  “Tell me more about your fears.”

A  Heart rate

B  Mental status

C  Blood pressure

D  Respiratory rate

A  Constipation

B  Crystalluria

C  Electrolyte imbalance

D  Mucosal irritation

A  Blurred vision, Vomiting, Decreased hearing

B  Nausea, Blurred vision, Decreased hearing

C  Nausea, Vomiting, Elevated liver enzymes

D  Blurred vision, Decreased hearing, Elevated liver enzymes

A  Change the patch.

B  Administer naloxone.

C  Call the primary health care provider.

D  Add a second patch.

A  0.4 mg

B  0.5 mg

C  0.8 mg

D  1 mg

A  Blood urea nitrogen (BUN) and creatinine levels

B  Neutrophil count

C  Aspartate transaminase (AST) and alanine transaminase (ALT) levels

D  Platelet count

A  Severe liver disease

B  Anemia

C  Joint pain

D  Asthma

A  Visceral pain

B  Deep pain

C  Superficial pain

D  Somatic pain

A  Severe pain resulting from cancer metastasis

B  Acute migraine

C  Lower back pain related to lumbar strain

D  Pain after abdominal surgery

A  Hydromorphone

B  Meperidine

C  Codeine sulfate

D  Fentanyl

A  Sudden onset

B  Sharp

C  Persistent

D  Sympathetic nervous system response

A  Naloxone

B  Acetylcysteine

C  Methylprednisolone

D  Flumazenil

A  To treat ischemic pain

B  To induce a state of unconsciousness

C  To relieve acute and chronic pain

D  To diminish feelings of anxiety

A  Referred pain

B  Phantom pain

C  Neuropathic pain

D  Vascular pain